期刊文献+

创伤性脑损伤后皮层基质金属蛋白酶-9的的表达

Cortical expression of matrix metalloproteinases-9 after human traumatic brain in jury
下载PDF
导出
摘要 目的探讨基质金属蛋白酶-9(MM P-9)在人创伤性脑损伤(TB I)后挫伤区皮层中的表达情况(表达位置、强度与时相)。方法挫伤区皮层的标本来自24例TB I患者,取样时间:伤后5 h^5 d。应用免疫组化技术测定MM P-9的表达情况。结果在TB I后的挫伤区皮层中,MM P-9表达明显上调,表达高峰为伤后24~48 h,主要在神经元中表达,神经胶质细胞中也有少量表达。结论MM P-9在TB I后的挫伤区皮层中表达上调,提示其可能在TB I后的病理生理过程中起着重要作用。 Objective: To analyze the expression of matrix metalloproteinases-9 (MMP-9) in contused human brain tissue and identify the expressive location, quantitation and time points. Methods: Contused brain tissue biopsies were obtained from 24 patients undergoing surgery for brain contusions 5 hours to 5 days after trauma. Expression of MMP-9 was detected by immunohistochemistry. Results: The result showed an immediate,strong and persistent up-regulation of MMP-9 in the area surrounding the iniured brain as early as 5 hours post-injury, and kept at high level up to 5 days post-iniury. The maximal expression of MMP-9 was detected at 24 to 48 hours post-injury. Expression of MMP-9 was mainly in neurons and a few neuroglial cells. Conclusion: The results suggest that MMP-9 is up-regulated obviously in the early phase of human brain contusion. MMP-9 might play important roles in the pathophysiological course after TBI,
出处 《山东医药》 CAS 北大核心 2006年第15期5-6,共2页 Shandong Medical Journal
关键词 创伤性脑损伤 基质金属蛋白酶-9 traumatic brain injury matrix metalloproteinases-9
  • 相关文献

参考文献9

  • 1牟晓燕,李怀臣,韩俊庆,黄琛,张维东.MMP_2和MMP_9在非小细胞肺癌组织中的表达[J].山东医药,2004,44(25):7-8. 被引量:8
  • 2Jiang X,Namura S, Nagata I. Matrix metalloproteinase inhibitor KB-R7785 attenuates brain damage resulting from permanent focal cerebral ischemia in mice[J]. Neurosci Lett. 2001,305(1):41-44.
  • 3Asahi M,Asahi K,Jung JC,et al. Role of matrix metalloproteinase-9 in focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94[J]. J Cereb Blood Flow Metab,2000, 20(12): 1681-1690.
  • 4Cuzner ML,Gveric D,Strand C,et al. The expression of tissuetype plasminogen activator, matrix metalloproteases and endogenous inhibitors in the central nervous system in multiple sclerosis: comparison of stages in lesion evolution [J].J Neuropathol Exp Neurol, 1996,55 (12): 1194-1204.
  • 5Zhuo M,Holtzman DM,Li Y,et al. Role of tisue plasminogen activator receptor LRP tn hippocampal long term potentiation[J]. J Neurosci, 2000,20(18): 542-549.
  • 6Gasche Y, Copin JC,Sugawara T, et al. Matrix metalloproteinase inhibition prevents oxidative stress-associated blood-brain barrier disruption after transient focal cerebral ischemia [J] .J Cereb Blood Flow Metab, 2001,21 (12):139-140.
  • 7Dzwonek J, Rylski M, Kaczmarek L. Matrix metalloproteinases and their endogenous inhibitors in neuronal physiology of the adult brain[J]. FEBS Lett,2004,567(11):129-135.
  • 8Rosenberg GA. Matrix metalloproteinases in neuroinflammation[J]. Glia,2002,39(3):279-291.
  • 9Markness KA, Adamson P, Susaman JD, et al. Dexamethasone regulation of matrix metalloproteinase expression in CNS vascular endothelium[J]. Brain, 2000,123 (4):698-709.

二级参考文献3

  • 1Maeta H,Ohgi S,Terada T,et al.Protein expression of matrix metallopro-teinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in papillary thyroid carcinomas.Virchows Arch,2001,438(2):121~128.
  • 2Nakamura H,Ueno H,Yamashita K,et al.Enhanced production andactivation of progelatinase A mediated by membrane type Ⅰmatrixmetalloproteinase in human papillary thyroid carcinomas.Cancer Res,1999,59(2):467~473.
  • 3李红梅,方伟岗,郑杰,张骏,由江峰,吴秉铨.不同转移潜能的人肿瘤细胞系金属蛋白酶活性分析[J].中华病理学杂志,1998,27(5):341-343. 被引量:47

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部